| Open-source software: not quite endsville. | |
| | |
MedLine Citation:
|
PMID: 15708537 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Open-source software will never achieve ubiquity. There are environments in which it simply does not flourish. By its nature, open-source development requires free exchange of ideas, community involvement, and the efforts of talented and dedicated individuals. However, pressures can come from several sources that prevent this from happening. In addition, openness and complex licensing issues invite misuse and abuse. Care must be taken to avoid the pitfalls of open-source software. |
| | |
Authors:
|
Matthew T Stahl |
Related Documents
:
|
17881587 - Shannon's monotonicity problem for free and classical entropy. 2137967 - Short self-retaining trocar sleeves for laparoscopic surgery. 15890887 - Freedom and rules: the acquisition and reprogramming of a bird's learned song. 11042817 - The fdi's first ten years, 1900-1910. fédération dentaire internationale. 17881587 - Shannon's monotonicity problem for free and classical entropy. 1769617 - Aids, older people, and social work. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Drug discovery today Volume: 10 ISSN: 1359-6446 ISO Abbreviation: Drug Discov. Today Publication Date: 2005 Feb |
Date Detail:
|
Created Date: 2005-02-14 Completed Date: 2005-09-01 Revised Date: 2005-11-16 |
Medline Journal Info:
|
Nlm Unique ID: 9604391 Medline TA: Drug Discov Today Country: England |
Other Details:
|
Languages: eng Pagination: 219-22 Citation Subset: IM |
Affiliation:
|
OpenEye Scientific Software, 3600 Cerrillos Road, Suite 1107, Santa Fe, NM 87507, USA. mstahl@eyesopen.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Access to Information Computational Biology / instrumentation*, trends Database Management Systems / trends Licensure Software* Software Design* |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The case for open-source software in drug discovery.
Next Document: Nonalcoholic steatohepatitis: recent advances from experimental models to clinical management.